Literature DB >> 33946741

Wound Fluid from Breast Cancer Patients Undergoing Intraoperative Radiotherapy Exhibits an Altered Cytokine Profile and Impairs Mesenchymal Stromal Cell Function.

Anne Wuhrer1, Stefanie Uhlig2, Benjamin Tuschy1, Sebastian Berlit1, Elena Sperk3, Karen Bieback2,4,5, Marc Sütterlin1.   

Abstract

Intraoperative radiotherapy (IORT) displays an increasingly used treatment option for early breast cancer. It exhibits non-inferiority concerning the risk of recurrence compared to conventional external irradiation (EBRT) in suitable patients with early breast cancer. Since most relapses occur in direct proximity of the former tumor site, the reduction of the risk of local recurrence effected by radiotherapy might partially be due to an alteration of the irradiated tumor bed's micromilieu. Our aim was to investigate if IORT affects the local micromilieu, especially immune cells with concomitant cytokine profile, and if it has an impact on growth conditions for breast cancer cells as well as mammary mesenchymal stromal cells (MSC), the latter considered as a model of the tumor bed stroma.42 breast cancer patients with breast-conserving surgery were included, of whom 21 received IORT (IORT group) and 21 underwent surgery without IORT (control group). Drainage wound fluid (WF) was collected from both groups 24 h after surgery for flow cytometric analysis of immune cell subset counts and potential apoptosis and for multiplex cytokine analyses (cytokine array and ELISA). It served further as a supplement in cultures of MDA-MB 231 breast cancer cells and mammary MSC for functional analyses, including proliferation, wound healing and migration. Furthermore, the cytokine profile within conditioned media from WF-treated MSC cultures was assessed. Flow cytometric analysis showed no group-related changes of cell count, activation state and apoptosis rates of myeloid, lymphoid leucocytes and regulatory T cells in the WF. Multiplex cytokine analysis of the WF revealed group-related differences in the expression levels of several cytokines, e.g., oncostatin-M, leptin and IL-1β. The application of WF in MDA-MB 231 cultures did not show a group-related difference in proliferation, wound healing and chemotactic migration. However, WF from IORT-treated patients significantly inhibited mammary MSC proliferation, wound healing and migration compared to WF from the control group. The conditioned media collected from WF-treated MSC-cultures also exhibited altered concentrations of VEGF, RANTES and GROα. IORT causes significant changes in the cytokine profile and MSC growth behavior. These changes in the tumor bed could potentially contribute to the beneficial oncological outcome entailed by this technique. The consideration whether this alteration also affects MSC interaction with other stroma components presents a promising gateway for future investigations.

Entities:  

Keywords:  GROα; IL-1β; RANTES; VEGF; breast cancer; intraoperative radiotherapy; leptin; mesenchymal stromal cells; oncostatin-M; tumor microenvironment

Year:  2021        PMID: 33946741     DOI: 10.3390/cancers13092140

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  52 in total

Review 1.  Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials.

Authors:  M Clarke; R Collins; S Darby; C Davies; P Elphinstone; V Evans; J Godwin; R Gray; C Hicks; S James; E MacKinnon; P McGale; T McHugh; R Peto; C Taylor; Y Wang
Journal:  Lancet       Date:  2005-12-17       Impact factor: 79.321

Review 2.  VEGF in Signaling and Disease: Beyond Discovery and Development.

Authors:  Rajendra S Apte; Daniel S Chen; Napoleone Ferrara
Journal:  Cell       Date:  2019-03-07       Impact factor: 41.582

Review 3.  Obesity and breast cancer: status of leptin and adiponectin in pathological processes.

Authors:  Michael E Grossmann; Amitabha Ray; Katai J Nkhata; Dmitry A Malakhov; Olga P Rogozina; Soner Dogan; Margot P Cleary
Journal:  Cancer Metastasis Rev       Date:  2010-12       Impact factor: 9.264

4.  Targeted intraoperative radiotherapy impairs the stimulation of breast cancer cell proliferation and invasion caused by surgical wounding.

Authors:  Barbara Belletti; Jayant S Vaidya; Sara D'Andrea; Frank Entschladen; Mario Roncadin; Francesca Lovat; Stefania Berton; Tiziana Perin; Ezio Candiani; Sonia Reccanello; Andrea Veronesi; Vincenzo Canzonieri; Mauro G Trovò; Kurt S Zaenker; Alfonso Colombatti; Gustavo Baldassarre; Samuele Massarut
Journal:  Clin Cancer Res       Date:  2008-03-01       Impact factor: 12.531

5.  Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis.

Authors:  Shih-Chieh Hung; Radhika R Pochampally; Sy-Chi Chen; Shu-Ching Hsu; Darwin J Prockop
Journal:  Stem Cells       Date:  2007-05-31       Impact factor: 6.277

Review 6.  Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials.

Authors:  S Darby; P McGale; C Correa; C Taylor; R Arriagada; M Clarke; D Cutter; C Davies; M Ewertz; J Godwin; R Gray; L Pierce; T Whelan; Y Wang; R Peto
Journal:  Lancet       Date:  2011-10-19       Impact factor: 79.321

7.  The hepatocyte growth factor regulatory factors in human breast cancer.

Authors:  Christian Parr; Gareth Watkins; Robert E Mansel; Wen G Jiang
Journal:  Clin Cancer Res       Date:  2004-01-01       Impact factor: 12.531

8.  Preclinical evaluation of mesenchymal stem cells overexpressing VEGF to treat critical limb ischemia.

Authors:  Julie R Beegle; Nataly Lessa Magner; Stefanos Kalomoiris; Aja Harding; Ping Zhou; Catherine Nacey; Jeannine Logan White; Karen Pepper; William Gruenloh; Geralyn Annett; Jan A Nolta; Fernando A Fierro
Journal:  Mol Ther Methods Clin Dev       Date:  2016-08-24       Impact factor: 6.698

9.  Surgical wound fluids from patients treated with intraoperative radiotherapy induce radiobiological response in breast cancer cells.

Authors:  Igor Piotrowski; Katarzyna Kulcenty; Dawid Murawa; Wiktoria Suchorska
Journal:  Med Oncol       Date:  2018-12-31       Impact factor: 3.064

10.  GROα overexpression drives cell migration and invasion in triple negative breast cancer cells.

Authors:  Kruttika Bhat; Marianna Sarkissyan; Yanyuan Wu; Jaydutt V Vadgama
Journal:  Oncol Rep       Date:  2017-05-24       Impact factor: 4.136

View more
  4 in total

1.  Long-Term Outcomes of an International Cooperative Study of Intraoperative Radiotherapy Upfront Boost With Low Energy X-Rays in Breast Cancer.

Authors:  Gustavo R Sarria; Maria L Ramos; Amalia Palacios; Ruben Del Castillo; Felipe Castro; Angel Calvo; Jose M Cotrina; Adela Heredia; Jose A Galarreta; Paola Fuentes-Rivera; Alicia Avalos; David A Martinez; Kevin Colqui; Gonzalo Ziegler; Leonard Christopher Schmeel; Luis V Pinillos; Frederik Wenz; Frank A Giordano; Gustavo J Sarria; Elena Sperk
Journal:  Front Oncol       Date:  2022-03-17       Impact factor: 6.244

2.  Inflammatory Breast Cancer: The Cytokinome of Post-Mastectomy Wound Fluid Augments Proliferation, Invasion, and Stem Cell Markers.

Authors:  Alshaimaa Tarek; Shrouk Khalaf El-Sayed; Wendy A Woodward; Mohamed El-Shinawi; Jon Mark Hirshon; Mona Mostafa Mohamed
Journal:  Curr Issues Mol Biol       Date:  2022-06-17       Impact factor: 2.976

3.  Pooled human bone marrow-derived mesenchymal stromal cells with defined trophic factors cargo promote dermal wound healing in diabetic rats by improved vascularization and dynamic recruitment of M2-like macrophages.

Authors:  Hélène Willer; Gabriele Spohn; Kimberly Morgenroth; Corinna Thielemann; Susanne Elvers-Hornung; Peter Bugert; Bruno Delorme; Melanie Giesen; Thomas Schmitz-Rixen; Erhard Seifried; Christiane Pfarrer; Richard Schäfer; Karen Bieback
Journal:  Front Immunol       Date:  2022-08-19       Impact factor: 8.786

4.  New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancer.

Authors:  Jayant S Vaidya; Max Bulsara; Michael Baum; Frederik Wenz; Samuele Massarut; Steffi Pigorsch; Michael Alvarado; Michael Douek; Christobel Saunders; Henrik Flyger; Wolfgang Eiermann; Chris Brew-Graves; Norman R Williams; Ingrid Potyka; Nicholas Roberts; Marcelle Bernstein; Douglas Brown; Elena Sperk; Siobhan Laws; Marc Sütterlin; Tammy Corica; Steinar Lundgren; Dennis Holmes; Lorenzo Vinante; Fernando Bozza; Montserrat Pazos; Magali Le Blanc-Onfroy; Günther Gruber; Wojciech Polkowski; Konstantin J Dedes; Marcus Niewald; Jens Blohmer; David McReady; Richard Hoefer; Pond Kelemen; Gloria Petralia; Mary Falzon; David Joseph; Jeffrey S Tobias
Journal:  Br J Cancer       Date:  2021-05-25       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.